Reactivation of latent tuberculosis in a COVID-19 patient on corticosteroid treatment
- PMID: 35545310
- PMCID: PMC9096484
- DOI: 10.1136/bcr-2021-247562
Reactivation of latent tuberculosis in a COVID-19 patient on corticosteroid treatment
Abstract
Though the COVID-19 pandemic has made international headlines since 2020, behind the scenes, tuberculosis (TB) has remained a leading cause of global mortality. According to the WHO, TB is 1 of the top 10 causes of death globally, with about one-quarter of the world's population infected. This case report highlights a female patient who presented to the emergency department with signs and symptoms of COVID-19 and was admitted to hospital. When the patient demonstrated minimal clinical improvement after initiating treatment for COVID-19, further investigations uncovered concomitant reactivated TB. This case is helpful in underscoring the potential implications of the COVID-19 pandemic and current treatment guidelines on the global burden of TB, which could subsequently impact how practitioners approach screening and management of latent TB infection.
Keywords: COVID-19; Global Health; TB and other respiratory infections.
© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis.Int J Mol Sci. 2021 Apr 6;22(7):3773. doi: 10.3390/ijms22073773. Int J Mol Sci. 2021. PMID: 33917321 Free PMC article. Review.
-
IGRA test for TB in COVID-19: role of corticosteroids.Int J Tuberc Lung Dis. 2022 Nov 1;26(11):1088-1091. doi: 10.5588/ijtld.22.0283. Int J Tuberc Lung Dis. 2022. PMID: 36281053 Free PMC article. No abstract available.
-
Screening and treatment of latent tuberculosis infection among HIV-infected patients in resource-rich settings.Expert Rev Anti Infect Ther. 2016;14(5):489-500. doi: 10.1586/14787210.2016.1168693. Expert Rev Anti Infect Ther. 2016. PMID: 26999724 Review.
-
COVID-19 and tuberculosis: the double whammy of respiratory pathogens.Eur Respir Rev. 2022 Apr 13;31(164):210264. doi: 10.1183/16000617.0264-2021. Print 2022 Jun 30. Eur Respir Rev. 2022. PMID: 35418488 Free PMC article. Review.
-
Role of latent tuberculosis infections in reduced COVID-19 mortality: Evidence from an instrumental variable method analysis.Med Hypotheses. 2020 Nov;144:110214. doi: 10.1016/j.mehy.2020.110214. Epub 2020 Aug 26. Med Hypotheses. 2020. PMID: 33254521 Free PMC article.
Cited by
-
Pathophysiological, immunological, and inflammatory features of long COVID.Front Immunol. 2024 Feb 28;15:1341600. doi: 10.3389/fimmu.2024.1341600. eCollection 2024. Front Immunol. 2024. PMID: 38482000 Free PMC article. Review.
-
A physiologically-based pharmacokinetic model for tuberculosis drug disposition at extrapulmonary sites.CPT Pharmacometrics Syst Pharmacol. 2023 Sep;12(9):1274-1284. doi: 10.1002/psp4.13008. Epub 2023 Jul 16. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37431175 Free PMC article.
-
Immunopathogenesis in SARS-CoV-2 and Mycobacterium tuberculosis: The danger of overlapping crises.Front Pharmacol. 2022 Nov 16;13:1065124. doi: 10.3389/fphar.2022.1065124. eCollection 2022. Front Pharmacol. 2022. PMID: 36467096 Free PMC article. No abstract available.
-
A Rare Case of Latent Tuberculosis Reactivation Secondary to a COVID-19 Infection.Infect Dis Rep. 2022 Jun 12;14(3):446-452. doi: 10.3390/idr14030048. Infect Dis Rep. 2022. PMID: 35735758 Free PMC article.
References
-
- Tuberculosis (TB). World Health organization, 2020. Available: https://www.who.int/news-room/fact-sheets/detail/tuberculosis [Accessed 12 Jun 2021].
-
- Health disparities. centers for disease control and prevention., 2020. Available: https://www.cdc.gov/tb/topic/populations/healthdisparities/default.htm [Accessed 12 Jun 2021].
-
- Global tuberculosis report 2021. World Health organization, 2021. Available: https://www.who.int/publications/digital/global-tuberculosis-report-2021...
-
- The end TB strategy. World Health organization, 2020. Available: https://www.who.int/tb/strategy/en/ [Accessed 12 Jun 2021].
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical